LCP
NVO

Legacy Capital Partners’s Novo Nordisk NVO Stock Holding History

Legacy Capital Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,050
Closed -$272K – 131
2018
Q1 		$272K Hold
11,050
– – 0.14% 108
2017
Q4 		$297K Sell
11,050
-800
-7% -$20.3K 0.15% 101
2017
Q3 		$285K Buy
11,850
+2,000
+20% +$45.2K 0.15% 100
2017
Q2 		$211K Buy
+9,850
New +$199K 0.11% 109
2016
Q4 		– Sell
-14,580
Closed -$304K – 113
2016
Q3 		$304K Buy
14,580
+200
+1% +$4.96K 0.19% 98
2016
Q2 		$387K Sell
14,380
-140
-1% -$3.84K 0.24% 91
2016
Q1 		$394K Sell
14,520
-100
-0.7% -$2.68K 0.25% 86
2015
Q4 		$425K Sell
14,620
-200
-1% -$5.54K 0.27% 80
2015
Q3 		$402K Hold
14,820
– – 0.27% 82
2015
Q2 		$406K Sell
14,820
-600
-4% -$16.9K 0.26% 86
2015
Q1 		$412K Buy
15,420
+820
+6% +$18.9K 0.26% 82
2014
Q4 		$309K Buy
14,600
+1,160
+9% +$25.9K 0.2% 93
2014
Q3 		$321K Sell
13,440
-3,200
-19% -$73.6K 0.21% 85
2014
Q2 		$385K Sell
16,640
-1,600
-9% -$35.3K 0.25% 80
2014
Q1 		$417K Sell
18,240
-2,300
-11% -$49K 0.3% 73
2013
Q4 		$380K Sell
20,540
-12,000
-37% -$209K 0.27% 77
2013
Q3 		$551K Buy
32,540
+1,950
+6% +$32.8K 0.41% 66
2013
Q2 		$475K Buy
+30,590
New +$509K 0.36% 69

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.2B AUM 1.48% 1-Year Est. Return

Legacy Capital Partners's NVO Position: Q2 2018 in Review

Legacy Capital Partners sold out of Novo Nordisk (NVO) in Q2 2018, closing a stake of 11,050 shares — an estimated $272K sold.

Legacy Capital Partners first reported a position in NVO in Q2 2013 and held it in 18 quarters. The position peaked at $551K in Q3 2013. 536 funds tracked by Wall St. Rank hold NVO as of Q2 2018.

  • Legacy Capital Partners reported no remaining Novo Nordisk position as of Q2 2018 after selling out during the quarter.
  • Legacy Capital Partners sold 11,050 Novo Nordisk shares in Q2 2018, an estimated $272K.
  • Legacy Capital Partners first reported a position in Novo Nordisk in Q2 2013 and held it in 18 quarters.
  • Legacy Capital Partners's Novo Nordisk position peaked at $551K in Q3 2013.
  • 536 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2018.

Based on Legacy Capital Partners's 13F filing for Q2 2018, filed 26 Jul 2018.